Bowman Dwight D, Grazette Alyssa R, Basel Chris, Wang Yingying, Hostetler Joseph A
Liberty Research, Inc., Waverly, NY, USA.
Bayer HealthCare LLC, Shawnee Mission, Kansas, USA.
Parasit Vectors. 2016 Jan 8;9:12. doi: 10.1186/s13071-016-1293-z.
Monthly heartworm preventives are designed to protect dogs by killing heartworms acquired the month prior to their administration, and after treatment with most products, the drug levels rapidly dissipate to very low levels. Work with Advantage Multi® for Dogs (imidacloprid + moxidectin) topical solution showed protection against hookworm infection throughout the month after administration of several monthly doses suggesting that similar protection might occur with heartworms. This study assessed the amount of protection afforded to dogs by the administration of four monthly doses of Advantage Multi for Dogs prior to infection with third-stage heartworm larvae (Dirofilaria immitis) 28 days after the last (fourth) treatment.
There were 16 purpose-bred mongrel dogs in the study that were divided into two groups, 8 control and 8 treated dogs. Dogs were housed in a manner preventing contact between animals and groups, and personal protective gear worn by staff minimised the chance spread of the topically applied product between runs. The dogs in the treated group received monthly applications of Advantage Multi for Dogs as per label instructions on Study Days 0, 28, 56, and 84. On Study Day 112, all 16 dogs received 50 third-stage larvae of D. immitis ("Missouri" isolate) via subcutaneous inoculation in the inguinal region. The study was terminated on Day 264, and the number of heartworms per dog was determined at necropsy.
Moxidectin levels after 4 treatments 28 days apart were near steady state on Study Day 112 when the dogs were inoculated with D. immitis third-stage larvae. At necropsy, 152 days after infection, all the control dogs had adult worms in their pulmonary arteries (geometric mean = 33.9; range 25-41), and none of the dogs treated four times prior to infection, with the last treatment 30 days prior to infection, harbored worms at necropsy.
The efficacy of prevention was 100% when the dogs were infected 28 days after the last monthly treatment. When dogs receive consecutive doses of Advantage Multi for Dogs as prescribed, heartworm infections will be prevented throughout the monthly dosing interval after administration of several monthly doses.
每月一次的心丝虫预防药物旨在通过杀死给药前一个月感染的心丝虫来保护犬只,并且在使用大多数产品进行治疗后,药物水平会迅速消散至非常低的水平。使用犬用爱沃克®(吡虫啉+莫昔克丁)外用溶液的研究表明,在连续几个月给药后的整个月内,对钩虫感染均有防护作用,这表明对心丝虫可能也有类似的防护效果。本研究评估了在最后一次(第四次)治疗28天后,对犬只施用四个月剂量的犬用爱沃克,然后感染第三期心丝虫幼虫(犬恶丝虫),犬只所获得的防护程度。
本研究中有16只专门繁育的杂种犬,分为两组,8只对照犬和8只治疗犬。犬只的饲养方式可防止动物之间及组间接触,工作人员穿戴的个人防护装备可最大程度减少外用产品在不同犬只间传播的可能性。治疗组的犬只在研究第0、28、56和84天按照标签说明每月施用一次犬用爱沃克。在研究第112天,所有16只犬只通过腹股沟区域皮下接种50条犬恶丝虫第三期幼虫(“密苏里”分离株)。研究在第264天结束,并在尸检时确定每只犬的心丝虫数量。
在研究第112天给犬只接种犬恶丝虫第三期幼虫时,每隔28天进行4次治疗后的莫昔克丁水平接近稳态。在感染后152天尸检时,所有对照犬的肺动脉中都有成虫(几何平均数=33.9;范围25 - 41),而在感染前接受4次治疗且最后一次治疗在感染前30天的犬只,尸检时均未发现心丝虫。
当犬只在最后一次每月治疗28天后感染时,预防效果为100%。当犬只按照规定连续施用犬用爱沃克时,在连续几个月给药后,整个月的给药间隔期内均可预防心丝虫感染。